Style | Citing Format |
---|---|
MLA | Tahmasebi E, et al.. "Investigation of the Expression Levels of Mir-21, Mir-132, Mir-29A, Mir-204, and Mir-138 in Patient's Plasma With Primary Osccs." Cellular and Molecular Biology, vol. 68, no. 12, 2022, pp. 26-31. |
APA | Tahmasebi E, Hakim LK, Yazdanian M, Asadi A, Garajei A, Nezaminia S, Daredor AMA, Khafaei M, Kahrizi S, Tavallaie M (2022). Investigation of the Expression Levels of Mir-21, Mir-132, Mir-29A, Mir-204, and Mir-138 in Patient's Plasma With Primary Osccs. Cellular and Molecular Biology, 68(12), 26-31. |
Chicago | Tahmasebi E, Hakim LK, Yazdanian M, Asadi A, Garajei A, Nezaminia S, Daredor AMA, Khafaei M, Kahrizi S, Tavallaie M. "Investigation of the Expression Levels of Mir-21, Mir-132, Mir-29A, Mir-204, and Mir-138 in Patient's Plasma With Primary Osccs." Cellular and Molecular Biology 68, no. 12 (2022): 26-31. |
Harvard | Tahmasebi E et al. (2022) 'Investigation of the Expression Levels of Mir-21, Mir-132, Mir-29A, Mir-204, and Mir-138 in Patient's Plasma With Primary Osccs', Cellular and Molecular Biology, 68(12), pp. 26-31. |
Vancouver | Tahmasebi E, Hakim LK, Yazdanian M, Asadi A, Garajei A, Nezaminia S, et al.. Investigation of the Expression Levels of Mir-21, Mir-132, Mir-29A, Mir-204, and Mir-138 in Patient's Plasma With Primary Osccs. Cellular and Molecular Biology. 2022;68(12):26-31. |
BibTex | @article{ author = {Tahmasebi E and Hakim LK and Yazdanian M and Asadi A and Garajei A and Nezaminia S and Daredor AMA and Khafaei M and Kahrizi S and Tavallaie M}, title = {Investigation of the Expression Levels of Mir-21, Mir-132, Mir-29A, Mir-204, and Mir-138 in Patient's Plasma With Primary Osccs}, journal = {Cellular and Molecular Biology}, volume = {68}, number = {12}, pages = {26-31}, year = {2022} } |
RIS | TY - JOUR AU - Tahmasebi E AU - Hakim LK AU - Yazdanian M AU - Asadi A AU - Garajei A AU - Nezaminia S AU - Daredor AMA AU - Khafaei M AU - Kahrizi S AU - Tavallaie M TI - Investigation of the Expression Levels of Mir-21, Mir-132, Mir-29A, Mir-204, and Mir-138 in Patient's Plasma With Primary Osccs JO - Cellular and Molecular Biology VL - 68 IS - 12 SP - 26 EP - 31 PY - 2022 ER - |